Non-tech. summaries 2014: projects on oncology
Projects granted during 2014 that have a primary purpose of basic research: oncology.
Documents
Details
This document outlines the projects granted under the Animals (Scientific Procedures) Act 1986 during 2014 with a primary purpose of basic research: oncology.
The following projects were granted:
-
identification and validation of novel therapeutic targets for human cancer (oncogenes, tumour suppressor genes, immune system, small molecule inhibitor, catechins)
-
significance of alternative slicing in vivo (tumours, metastasis, splice factors)
-
controlling CD8+ T cell-mediated immune responses to tumours (cancer tumour immunity)
-
pathogenesis of avian oncogenic viruses (Marek’s disease, avian leukosis, lymphomas, reticuloendotheliosis, multiple infections)
-
studies on cancer cachexia and obesity/type II diabetes (cachexia, tumour factors, weight loss, diabetes)
-
studies on urological cancer (prostate cancer, bladder cancer, kidney cancer)
-
brain metastasis: imaging and inflammation (brain, tumour, imaging, inflammation, metabolism)
-
role of inflammation in pancreatic cancer (cancer, inflammation, tumour micro environment, pancreas)
-
generation and characterisation of human derived tumour xenografts or PDXs (breast cancer in vivo expansion engraftment)
-
FAP+ stromal cell response to biological stress (cancer, lymphocytes, cachexia, metabolism, development)
-
metabolic dysfunction in cancer progression (mitochondria, autophagy, CAFs, oxidative phosphorylation, caveolin)
-
ribosomal and metabolic stress responses in cancer (ribosome, metabolism, cancer, therapy, stress)
-
signalling pathways in physiology and oncogenesis (genes, cells, signalling, development, cancer)
-
targeted mouse models for pre-clinical studies (genetically engineered mouse models, cancer, targeted therapeutics, pre-clinical)
-
targeted therapy for cancer (cancer, gene therapy, radiation, radiosensitiser, virus therapy)
-
temporal analysis of cancer evolution in vivo (cancer, biomarker, therapy)
-
manipulating cellular and microenvironment crosstalk in chronic inflammation and cancer (lung cancer, inflammation, micro environment)
-
gene function in tumorigenesis (cancer, colorectal cancer, drug targets, targeted drug delivery, diagnosis)
-
biochemical investigations of the heart (heart failure, metabolism, mitochondria, contractile dysfunction)
-
analysis of cancer gene phenotypes (oncogene, tumour suppressor gene, tumour formation)
-
genetic determinants of cancer metastasis (cancer, metastasis)
-
bispecific antibodies for use in cancer therapies (cancer, immunotherapy, bispecific antibodies)
-
diagnosis and therapy of gastrointestinal cancer (cancer, abdomen, optical imaging)
-
action of and intervention in control pathways in cancer (kinase, cancer, drugs)
-
investigation of RAS oncogene mutant cancers (lung cancer, therapy, early detection)
-
investigating cellular protein production (cancer, protein production, gene expression)
-
the phosphoinositide-network in health and disease (inflammation, cancer)
-
understanding the molecular basis for invasion and metastasis of melanoma and pancreatic cancer (cancer metastasis, pancreatic cancer, melanoma)
-
PTEN and the PI 3-kinase signalling pathway (cancer, signalling, pten, tumour suppressor)
-
cancer biology including host immunity in zebrafish (cancer, immunity, zebrafish)
-
the tumour micro environment in cancer progression (cell death, inflammation, lymphoma)
-
mechanisms of normal and leukaemic haematopiesis (haematopoietic stem cells; leukaemia; haematopoiesis)
-
understanding the repair of damaged DNA (DNA damage; repair; cancer; chemotherapy)
-
mechanisms of cancer development (cancer, heterogeneity, stem cells, epigenetic)
-
development and refinement of small animal imaging (imaging, development, biomarkers)
-
novel therapies for malignant germ cell tumours (MicroRNA, germ cell tumour)
-
molecular imaging of cancer (imaging, cancer, instrumentation, contrast)
-
genetics and treatment of acute lymphoblastic leukaemia (acute lymphoblastic leukaemia, measles virus)
-
progressive multifocal leukoencephalopathy (PML) and its network in tissue development and disease (cancer, stem cells)
-
models of lymphomas to identify therapeutic targets (lymphoma, micro environment, targeted therapy)
- targeted molecular and immune therapies for cancer (cancer, melanoma, immune response, inflammation, immunotherapy)
- regeneration and cancer in epithelial tissues (stem-cells; regeneration; tumour; epithelial tissues)